Featured Research

from universities, journals, and other organizations

Genetic Change Extends Mouse Life, Points To Possible Treatment For Amyotrophic Lateral Sclerosis

Date:
December 18, 2008
Source:
University of Wisconsin-Madison
Summary:
There are many ways to die, but amyotrophic lateral sclerosis, also known as Lou Gehrig's disease must be one of the worst. By the time a patient notices muscle weakness, the neurons that control the muscles have already begun dying, in an untreatable process that brings death within two to five years.

There are many ways to die, but amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease must be one of the worst. By the time a patient notices muscle weakness, the neurons that control the muscles have already begun dying, in an untreatable process that brings death within two to five years.

In a series of experiments reported December 9 in the Journal of Neuroscience, a University of Wisconsin-Madison pharmacy researcher was able to prolong life and slow nerve deterioration in a mouse with a genetic form of ALS, or amyotrophic lateral sclerosis. Marcelo Vargas, a postdoctoral fellow in the laboratory of Jeff Johnson, professor in the School of Pharmacy, tested mice that carried an extra gene that pushed support cells for the neurons into overdrive, causing them to pump out extra quantities of the anti- oxidant glutathione.

The gene in question, called Nrf2, has long been a research focus for Johnson, who is also a Waisman Center investigator.

Although oxidation is a major cause of cell death in Parkinson's disease and Alzheimer's disease as well as ALS, antioxidant treatments have failed to slow these diseases.

But the mice with extra copies of Nrf2 produced glutathione right alongside the vulnerable neurons, and that made all the difference, says Johnson. These special mice were engineered in collaboration with Albee Messing, a professor in the UW-Madison School of Veterinary Medicine and also an investigator at the Waisman Center. "It's extremely difficult to increase glutathione in the central nervous system," Johnson says. "You can't just shoot it into people or animals. But we found a 25 percent increase in the molecule in the spinal cords."

Although the mice did eventually die of ALS, they lived longer, and the disease appeared 17 days later than in mice that lacked the extra Nrf2 gene, Johnson says. "This was a very aggressive model of ALS, so a life extension of 21 days is thought to be pretty significant, roughly equivalent to five to 10 years in human patients."

The inserted Nrf2 gene was only active in support cells called astrocytes, which promote health among the neurons that actually carry nerve signals, Johnson explains. "We have taken this normal function of producing antioxidants and added to it. It's like putting the astrocytes on steroids."

Experiments performed on mouse astrocytes and nerve cells in a dish confirmed the source of the protection, Johnson adds. "We can completely reverse the toxicity of the sick astrocytes. The mutated protein that causes ALS is still there, but Nrf2 makes glutathione that completely blocks it."

Although the mice that Johnson tested carried the inherited form of ALS, most patients do not have an inherited disease. However, Johnson says the mice are still a good testbed for ALS treatments. "The endpoints that we are blocking, including death of neurons and separation of neurons from the muscle, are seen in all forms of ALS; that's what makes this so exciting. We are not targeting the mutant protein that causes the disease; we are targeting the astrocytes' mechanism that preserves the neurons. The mutant protein is still in all cells of the spinal cord; we are just over-expressing the Nrf2 gene — causing it to make more glutathione — and that provides the protection."

Nrf2 activates a system, or pathway, that is also attracting interest from researchers working on Parkinson's disease, Alzheimer's disease, Huntington's disease and stroke, says Johnson. "It's been exciting. This hypothesis came to me when I was in graduate school in 1990, and this year it seems to be coming to fruition" as a possible treatment for several neurodegenerative diseases.

The results may be promising, but inserting genes, or gene therapy, has had few successes to date. Yet by positively identifying the chemical pathway that keeps neurons healthy in ALS, Johnson is in a position to search for a drug that can enter the brain and activate the Nrf2 system. That quest is already under way at an automated screening facility at UW-Madison, where more than 50,000 molecules are being tested for their ability to activate Nrf2.

Years of research will be needed before today's results can be translated into a treatment for patients, however. "If everything worked perfectly, we probably could have something in two to three years, but the odds of that happening are pretty low," says Johnson. "But in five to eight years, I hope to have something can get through all the regulatory hoops."

Finding that one mechanism is involved in several neurodegenerative diseases is significant, Johnson says, because it attracts a broader group of scientists and funders to the work. "Something seems to be going wrong with the neurons because the astrocyte does not function right. Now, it looks like we have the potential to fix the astrocyte, so it can preserve the neurons for a longer period."

Delinda Johnson and Daniel Sirkis were also members of the UW-Madison research team. The study was funded by the Robert Packard Center for ALS Research at Johns Hopkins, the ALS Association and National Institutes of Health grants.


Story Source:

The above story is based on materials provided by University of Wisconsin-Madison. Note: Materials may be edited for content and length.


Cite This Page:

University of Wisconsin-Madison. "Genetic Change Extends Mouse Life, Points To Possible Treatment For Amyotrophic Lateral Sclerosis." ScienceDaily. ScienceDaily, 18 December 2008. <www.sciencedaily.com/releases/2008/12/081209221515.htm>.
University of Wisconsin-Madison. (2008, December 18). Genetic Change Extends Mouse Life, Points To Possible Treatment For Amyotrophic Lateral Sclerosis. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2008/12/081209221515.htm
University of Wisconsin-Madison. "Genetic Change Extends Mouse Life, Points To Possible Treatment For Amyotrophic Lateral Sclerosis." ScienceDaily. www.sciencedaily.com/releases/2008/12/081209221515.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins